ATRA
Atara Biotherapeutics Inc
Price:  
0.51 
USD
Volume:  
1,280,110.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atara Relative Valuation

-11483.9%
Upside

As of 2024-06-16, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is (58.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.51 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is -11483.9%.

The range of the Relative Valuation is (58.81) - (57.15) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 30.4x - 35.6x 30.9x
Forward P/E multiples 26.0x - 29.5x 29.2x
Fair Price (58.81) - (57.15) (58.17)
Upside -11608.9% - -11283.1% -11483.9%
0.51 USD
Stock Price
(58.17) USD
Fair Price

Atara Relative Valuation - Historical P/E Data

Date P/E
2024-06-14 -0.26
2024-06-13 -0.27
2024-06-12 -0.28
2024-06-11 -0.29
2024-06-10 -0.27
2024-06-07 -0.27
2024-06-06 -0.29
2024-06-05 -0.30
2024-06-04 -0.29
2024-06-03 -0.30
2024-05-31 -0.29
2024-05-30 -0.29
2024-05-29 -0.29
2024-05-28 -0.32
2024-05-24 -0.32
2024-05-23 -0.34
2024-05-22 -0.36
2024-05-21 -0.36
2024-05-20 -0.37
2024-05-17 -0.32
2024-05-16 -0.31
2024-05-15 -0.33
2024-05-14 -0.31
2024-05-13 -0.29
2024-05-10 -0.27
2024-05-09 -0.28
2024-05-08 -0.29
2024-05-07 -0.31
2024-05-06 -0.33
2024-05-03 -0.35
2024-05-02 -0.34
2024-05-01 -0.35
2024-04-30 -0.36
2024-04-29 -0.37
2024-04-26 -0.36
2024-04-25 -0.36
2024-04-24 -0.37
2024-04-23 -0.37
2024-04-22 -0.36
2024-04-19 -0.34
2024-04-18 -0.36
2024-04-17 -0.37
2024-04-16 -0.35
2024-04-15 -0.35
2024-04-12 -0.37
2024-04-11 -0.37
2024-04-10 -0.37
2024-04-09 -0.39
2024-04-08 -0.39
2024-04-05 -0.40